Quasar Medical Invests in CathPrint to Advance Next-Generation Catheter Technology
SINGAPORE - STOCKHOLM, SWEDEN November 10, 2026 – Quasar Medical today announced a minority investment in CathPrint, a Swedish developer of flexible-electronics architectures. The two companies have also entered into a strategic collaboration agreement to offer enhanced catheter design and development services leveraging CathPrint’s proprietary technology.
The CathPrint Technology Platform enables the integration of flexible printed circuits onto catheter shafts, replacing individual wires and enabling an automated assembly. The e -Shaft™ platform’s catheter-shaft implementation supports higher electrode density, greater design freedom and scalable manufacturing.
Based on CathPrint’s calculations, active operator time for electrode assembly on a 10-electrode catheter, including loading and unloading, could be reduced from approximately 1.5–2 hours down to 10 minutes. In a separate customer-specific case, CathPrint’s calculations indicated the potential to reduce electrode assembly cost by approximately 67%.
“Our investment in CathPrint reflects Quasar’s commitment to advance technologies that may shape the next generation of minimally invasive medical devices,” said Alex Wallstein, Chief Executive Officer of Quasar Medical. “As catheter designs become increasingly complex, innovations in flexible electronics may simplify manufacturing and enable more advanced functionality. We look forward to exploring how our collaboration can help medical device innovators bring new solutions to market.”
The companies have also entered into a strategic collaboration agreement to explore catheter design and development opportunities using CathPrint’s proprietary technology. CathPrint remains an independent company. The collaboration aims to introduce CathPrint’s technology to a broader international customer base, drawing on Quasar’s global presence and relationships with medical device companies.
“Quasar’s investment reflects confidence in the potential of CathPrint’s platform and marks an important step towards commercial scale. We look forward to working together to enable new catheter designs, support scalable manufacturing and bring our technology to a broader international market,” said Jacob Ahlsson, CEO, CathPrint AB.
CathPrint’s platform is applicable across multiple catheter segments, including EP mapping, pulsed field ablation (PFA), balloon and basket catheters, and advanced sensing and navigation. The company has been engaged in development programs with catheter OEMs and CDMOs since 2022.
About CathPrint
CathPrint is a Swedish MedTech company and specialist contract development and manufacturing organization (CDMO). Its proprietary CathPrint Technology Platform integrates flexible printed circuits onto catheter shafts, replacing individual wires and enabling higher electrode density, greater design freedom and scalable manufacturing. Key applications include electrophysiology mapping and ablation, including PFA. CathPrint also provides specialist development and manufacturing services based on its technology.
About Quasar Medical
Quasar Medical is a global contract development and manufacturing organization (CDMO) with more than 38 years of experience delivering innovative solutions for minimally invasive medical devices. From design and development through full-scale manufacturing, Quasar partners with leading medical device companies to bring complex technologies to market with speed, quality, and precision.
With 11 global locations and approximately 5,000 employees, Quasar provides expertise across complex catheters, medical balloons, steerable systems, nitinol technologies, electromagnetic (EM) sensors, and complex assemblies. Quasar is ISO 13485 certified and compliant with cGMP standards, while combining global scale with engineering excellence to help customers accelerate innovation and improve patient outcomes.
For more information about Quasar Medical, visit www.quasarmedical.com.
Media Contacts
Quasar Medical: Gina Fields, Director, Global Marketing – gina.fields@quasar-med.com
CathPrint: Jacob Ahlsson, CEO – jacob.ahlsson@cathprint.se